<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1223797</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2023.1223797</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Advances in biofabrication for skin regeneration</article-title>
<alt-title alt-title-type="left-running-head">Dias et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2023.1223797">10.3389/fbioe.2023.1223797</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Dias</surname>
<given-names>Juliana R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/848378/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Longoni</surname>
<given-names>Alessia</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oliveira</surname>
<given-names>Ana L.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Centre for Rapid and Sustainable Product Development</institution>, <institution>Instituto Polit&#xe9;cnico de Leiria</institution>, <addr-line>Marinha Grande</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Orthopaedic Surgery and Musculoskeletal Medicine Centre for Bioengineering and Nanomedicine</institution>, <institution>University of Otago Christchurch</institution>, <addr-line>Christchurch</addr-line>, <country>New Zealand</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>CBQF&#x2014;Centro de Biotecnologia e Qu&#xed;mica Fina&#x2014;Laborat&#xf3;rio Associado</institution>, <institution>Escola Superior de Biotecnologia</institution>, <institution>Universidade Cat&#xf3;lica Portuguesa</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/120336/overview">Hasan Uludag</ext-link>, University of Alberta, Canada</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Juliana R. Dias, <email>juliana.dias@ipleiria.pt</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1223797</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>05</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Dias, Longoni and Oliveira.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Dias, Longoni and Oliveira</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Bioeng. Biotechnol." xlink:href="https://www.frontiersin.org/researchtopic/37031" ext-link-type="uri">Editorial on the Research Topic <article-title>Advances in biofabrication for skin regeneration</article-title> </related-article>
<kwd-group>
<kwd>TE-based skin substitutes</kwd>
<kwd>wound healing</kwd>
<kwd>hybrid structures</kwd>
<kwd>
<italic>in situ</italic> approaches</kwd>
<kwd>controlled drug delivery</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Biomaterials</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The development of TE-based skin substitutes is one of the most promising approaches to achieve efficient skin regeneration in the case of acute and chronic wounds (<xref ref-type="bibr" rid="B3">Ferreira et al., 2021</xref>; <xref ref-type="bibr" rid="B2">Dias et al., 2022</xref>). In fact, biofabrication strategies have demonstrated that is possible to produce advanced structures that mimic the morphology, properties, and functions of skin ECM, promoting faster and reliable wound healing (<xref ref-type="bibr" rid="B1">Dias et al., 2020</xref>).</p>
<p>This Research Topic includes interesting and innovative research papers that can lead to advances in the field of TE-based skin substitute development. Immediately after a skin injury occurs, a cascade of events begin, with haemostasis being the first. Thus, bleeding control and wound protection is crucial. In the study by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmats.2022.944274/full">Zhang et al.</ext-link>, a carboxymethyl cellulose/carboxymethyl chitosan-polydopamine (CMC/CMCS-PDA) sponge exhibiting <italic>in vivo</italic> skin haemostasis and repair properties was developed. Additionally, it presented good antibacterial and antioxidant properties. The second research paper included in this Research Topic is the study by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2022.930551/full">Wang et al.</ext-link>, where 3D-printed egg white hydrogels promoting adipose-derived stem cells (ASCs) adhesion and proliferation without cytotoxicity were developed. Furthermore, <italic>in vivo</italic> results showed the ability of these ASC-seeded hydrogels to accelerate wound healing through the enhancement of fibroblast proliferation, angiogenesis, and collagen rearrangement in the wound bed. In another interesting clinical study, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2022.979834/full">Xue et al.</ext-link> demonstrated the effectiveness of injectable platelet-rich fibrin (i-PRF), produced via a simple two-centrifugation method combined with vacuum sealing drainage, in reducing wound inflammation and promoting scar formation in patients with chronic refractory wounds (CRW).</p>
<p>Another important aspect that should be considered when aiming to regenerate skin is wound infection, as the presence of a bacterial infection could delay the healing process. Considering that antimicrobial resistance is one of the greatest global public health challenges of our time, the search for alternatives to antibiotics is crucial for wound management. Based on this, this Research Topic includes a review article by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2022.913912/full">Alipoor et al.</ext-link>, in which the bactericidal activity of hyaluronic acid (HA) was detailed together with a summary of the HA structure, its production and properties, and its various platforms as a carrier in drug delivery.</p>
<p>Overall, the reports presented in this Research Topic highlight the importance of advanced approaches to treat wounds, to promote haemostasis, and to develop new alternatives to synthetic antibiotics. As Research Topic Editors, we are deeply grateful to all the authors for their outstanding-quality research and to all the reviewers for their critical evaluations of the manuscripts.</p>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec id="s2">
<title>Funding</title>
<p>This work was supported by the European Regional Development Fund (ERDF) through the COMPETE 2020&#x2014;Operational Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funding through the Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e a Tecnologia (FCT)/Minist&#xe9;rio da Ci&#xea;ncia, Tecnologia e Inova&#xe7;&#xe3;o, grant numbers: UIDB/04044/2020, UIDP/04044/2020, InnovaBIOMAS&#x2014;2022.10564. PTDC, and INOV. AM&#x2014;Inova&#xe7;&#xe3;o em fabrica&#xe7;&#xe3;o aditiva (C644865234-00000004). Moreover, this study has received funding from the European Union&#x2019;s Horizon Europe research and innovation programme under grant number 101079372.</p>
</sec>
<sec sec-type="COI-statement" id="s3">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s4">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dias</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Baptista-Silva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Costa-Pinto</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>
<italic>In situ</italic> enabling approaches for tissue regeneration: Current challenges and new developments</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>8</volume>, <fpage>85</fpage>.</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dias</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Augusto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>B&#xe1;rtolo</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Granja</surname>
<given-names>P. L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Electrospun polycaprolactone (PCL) degradation: An <italic>in vitro</italic> and <italic>in vivo</italic> study</article-title>. <source>Polymers</source> <volume>14</volume> (<issue>16</issue>), <fpage>3397</fpage>.</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Janu&#xe1;rio</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>F&#xe9;lix</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lemos</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Multifunctional gelatin/chitosan electrospun wound dressing dopped with Undaria pinnatifida phlorotannin-enriched extract for skin regeneration</article-title>. <source>Pharmaceutics</source> <volume>13</volume> (<issue>12</issue>), <fpage>2152</fpage>.</citation>
</ref>
</ref-list>
</back>
</article>